SOX2 overexpression correlates with poor prognosis in laryngeal squamous cell carcinoma

SOX2 may contribute to the malignant progression of laryngeal squamous cell carcinoma (LSCC), and present as a useful prognostic marker and a potential therapeutic target for LSCC patients.